BioLargo, Inc. · Irvine, CA United States (OTC: BLGO)
Key BioLargo, Inc. Financials
| Company Type | Public -(OTC: BLGO) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2001 Sales (mil.) | $0.7 |
| 2010 Employees | 3 |
BioLargo, Inc. Stock Quote (OTC: BLGO)
| Latest 02/15/12 15:34:46 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $0.39 | 0.000 | 0.000 | $0.00 | $0.00 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
BioLargo, Inc. Income Statement
| Dec 01 | Dec 00 | Dec 99 | |
| Revenue | 0.7 | 0.8 | 1.9 |
| Cost of Goods Sold | 0.1 | 0.1 | 0.0 |
| Gross Profit | 0.6 | 0.7 | 1.9 |
| Gross Profit Margin | 84.1% | 85.7% | 98.8% |
| SG&A Expense | 4.0 | 2.6 | 1.8 |
| Depreciation & Amortization | 0.2 | 0.3 | 0.2 |
| Operating Income | (6.8) | (2.1) | (0.1) |
| Operating Margin | -905.3% | -257.9% | -6% |
| Nonoperating Income | 0.1 | 0.0 | (1.5) |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (6.7) | (2.1) | (1.5) |
| Income Taxes | 0.0 | (0.0) | |
| Net Income After Taxes | (6.7) | (2.1) | (1.5) |
| Continuing Operations | (6.7) | (2.1) | (1.5) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (6.7) | (2.1) | (1.5) |
| Total Net Income | (6.7) | (2.1) | (1.5) |
| Net Profit Margin | -887.2% | -254% | -80.2% |
| Diluted EPS from Total Net Income | (39.00) | (15.75) | (11.50) |
| Dividends per Share | 0.0 | 0.0 | 0.0 |
All amounts in millions of US Dollars except per share amounts.
BioLargo, Inc. Balance Sheet
| Assets | Dec 01 | Dec 00 | Dec 99 |
| Current Assets | |||
| Cash | 0.4 | 4.4 | 0.8 |
| Net Receivables | 0.2 | 1.4 | 1.6 |
| Inventories | 0.5 | 0.5 | 0.6 |
| Other Current Assets | 0.2 | 0.1 | 0.2 |
| Total Current Assets | 1.3 | 6.5 | 3.2 |
| Net Fixed Assets | 2.4 | 3.8 | 4.6 |
| Other Noncurrent Assets | 0.9 | 0.1 | 0.2 |
| Total Assets | 4.6 | 10.3 | 8.1 |
| Liabilities | Dec 01 | Dec 00 | Dec 99 |
| Current Liabilities | |||
| Accounts Payable | -- | -- | -- |
| Short-Term Debt | 2.4 | 3.5 | -- |
| Other Current Liabilities | 1.0 | 0.2 | 0.2 |
| Total Current Liabilities | 3.4 | 3.7 | 0.2 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 0.0 | 0.0 | 0.0 |
| Total Liabilities | 3.4 | 3.7 | 0.2 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 1.2 | 6.6 | 7.9 |
| Total Equity | 1.2 | 6.6 | 7.9 |
| Shares Outstanding (thou.) | 169.0 | 48,855.0 | 42,897.8 |
All amounts in millions of US Dollars except per share amounts.
BioLargo, Inc. Cash Flow Statement
| Dec 01 | Dec 00 | Dec 99 | |
| Net Operating Cash Flow | (2) | (1) | (0) |
| Net Investing Cash Flow | (2.4) | 0.5 | (0.8) |
| Net Financing Cash Flow | 0.0 | 4.2 | 0.0 |
| Net Change in Cash | (4.0) | 3.6 | (0.8) |
| Depreciation & Amortization | 0.2 | 0.3 | 0.2 |
| Capital Expenditures | (1.8) | (0.8) | |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.